PriceTargets.com logo

MBody AI - MBAI Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $10.00
  • Forecasted Upside: 211.53%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.21 As of 10/7/2026 05:00 PM ET
▼ -0.03 (-0.93%)

This chart shows the closing price for MBAI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New MBody AI Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MBAI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MBAI

Analyst Price Target is $10.00
▲ +211.53% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for MBody AI in the last 3 months. The average price target is $10.00, with a high forecast of $10.00 and a low forecast of $10.00. The average price target represents a 211.53% upside from the last price of $3.21.

This chart shows the closing price for MBAI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in MBody AI. This rating changed within the last month from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/15/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/14/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/12/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/10/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
4/10/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
7/9/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
9/7/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/7/2026

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/29/2026Zacks ResearchUpgradeHold
9/28/2026Northland SecuritiesInitiated CoverageOutperform$10.00
7/21/2026Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
4/24/2026Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
1/26/2026Weiss RatingsInitiated CoverageSell (D-)
(Data available from 10/8/2021 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/12/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/11/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/11/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/10/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/10/2026
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/9/2026
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/8/2026
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/8/2026

Current Sentiment

  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
MBody AI logo
MBody AI, Inc. (NASDAQ:MBAI) is a technology company focused on applying artificial intelligence to health, wellness and body-composition management. Its business centers on developing digital tools intended to help users better understand and manage aspects of their fitness, nutrition and overall well-being. The company’s products and services are designed to use data-driven insights and personalized recommendations to support individual health and wellness goals. Publicly available information about MBody AI’s specific product portfolio, operating geographies and leadership team is limited. MBody AI is an emerging company, and additional details about its commercial operations and corporate history may become available through future regulatory filings and company disclosures.
Read More

Today's Range

Now: $3.21
Low: $3.16
High: $3.35

50 Day Range

MA: $6.64
Low: $3.06
High: $10.01

52 Week Range

Now: $3.21
Low: $3.03
High: $27.44

Volume

20,932 shs

Average Volume

22,463 shs

Market Capitalization

$4.43 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.66

Frequently Asked Questions

What sell-side analysts currently cover shares of MBody AI?

The following Wall Street analysts have issued stock ratings on MBody AI in the last twelve months: Northland Securities, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for MBAI.

What is the current price target for MBody AI?

0 Wall Street analysts have set twelve-month price targets for MBody AI in the last year. Their average twelve-month price target is $10.00, suggesting a possible upside of 211.5%. Northland Securities has the highest price target set, predicting MBAI will reach $10.00 in the next twelve months. Northland Securities has the lowest price target set, forecasting a price of $10.00 for MBody AI in the next year.
View the latest price targets for MBAI.

What is the current consensus analyst rating for MBody AI?

MBody AI currently has 1 sell rating, 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MBAI, but not buy more shares or sell existing shares.
View the latest ratings for MBAI.

What other companies compete with MBody AI?

Other companies that are similar to MBody AI include HeartSciences, Femasys, SeaStar Medical, IRIDEX and Cytosorbents. Learn More about companies similar to MBody AI.

How do I contact MBody AI's investor relations team?

MBody AI's physical mailing address is 29 Abba Hushi Ave., P.O. Box 1271, Isfiya, HA, 3009000. The company's listed phone number is 972-4-8303400 and its investor relations email address is [email protected]. The official website for MBody AI is www.mbody.ai. Learn More about contacing MBody AI investor relations.